Browsing Tag
Washington University School of Medicine
3 posts
C2N Diagnostics wins FDA clearance for PrecivityAD2 as Alzheimer’s blood testing race widens
C2N Diagnostics has secured FDA clearance for PrecivityAD2, extending regulated Alzheimer’s blood testing to symptomatic adults as young as 40 and intensifying competition with established diagnostic platforms.
Lunit submits FDA filing for AI mammography model: What’s next for U.S. breast cancer screening?
Find out how Lunit’s FDA-bound artificial intelligence risk model could change breast cancer screening and prevention in the United States. Read the full story.
Eisai’s etalanetug earns FDA Fast Track status, signaling new hope in Alzheimer’s therapy
Eisai’s etalanetug gets FDA Fast Track for Alzheimer’s, signaling a major shift toward tau-targeting therapies. Find out what this means for investors.